Atlas market file · Equity · United States
Bioceres Crop Solutions Corp.BIOX
- Last close
- 0.36
- Change
- -1.10%
- 96-bar range
- 0.301 – 0.7
- As of
- 6 Aug 2026
Bioceres Crop Solutions Corp. is an agricultural chemicals issuer listed as BIOX on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-96.38% over the window).
Source rail: Yahoo Finance chart API (BIOX). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for BIOX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
BIOX public profile
Agricultural chemicals issuer. Bioceres Crop Solutions Corp. is connected to current market context, cited company sources and its retained research file.
Bioceres Crop Solutions Corp. trades as BIOX on NASDAQ. Bioceres Crop Solutions Corp. (BIOX) has a latest verified close of 0.36, down 1.10%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files BIOX under USA Stocks for browsing.
What changed for Bioceres Crop Solutions Corp. today
Bioceres Crop Solutions Corp. reported total revenues of $39.4 million for the fiscal third quarter ended March 31, 2026-a 23% year-over-year decline driven by softer demand and competitive pressure in crop protection, plus the ongoing transition in its seeds business. The company, which styles itself as a leader in productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, posted a net loss of $10.0 million and adjusted EBITDA of negative $0.6 million in the same period.
The business sits at the intersection of ag-tech and climate narrative, selling products it claims reliably and cost-effectively support climate-smart practices while increasing yields and quality. Its flagship HB4 drought-tolerant wheat is approved in Argentina and Brazil, and the company publishes environmental assessments alongside its product pipeline, positioning itself as both an innovator and an emissions-conscious operator. Yet the headline numbers show a company struggling to translate its sustainability story into sales growth.
Filings detail a third-quarter loss of $10.0 million on revenues of $39.4 million, with adjusted EBITDA at negative $0.6 million. The company describes its mission as “making crops more resilient to climate change,” but the income statement reads like a stress test under real-world drought conditions. Management will host a results conference call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time; the original invite required correction, with the US toll-free number updated to 1-833-461-5787 and the conference ID revised to 717574163. The updated invite and product imagery are available on the investor site.
Investors can review the official product and sustainability pages for the company’s positioning and pipeline, while the financial press kit and multimedia assets outline its narrative. The sustainability page highlights efforts to reduce the GHG emissions footprint of operations even as it commercialises products aimed at climate-smart agriculture. The investor relations rail also includes the corrected conference call details and product imagery, which frame the company’s public messaging. For a closer look at the operating metrics and segment dynamics, the third-quarter results release is the primary source.
If you’re tracking this story for datapoints, the revenue decline and negative adjusted EBITDA are the two figures worth anchoring to. The rest of the narrative-regeneration, resilience, climate-smart-is marketing until the cash flow turns positive. The company’s own filings and product pages set the official story; the quarterly numbers set the reality. Until that changes, the gap between pitch and P&L remains the story to watch.
Sources & evidence · 5 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
BIOX technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on BIOX
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep BIOX research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
BIOX FAQ
What is Bioceres Crop Solutions Corp. (BIOX)?Bioceres Crop Solutions Corp. (BIOX) has a latest verified close of 0.36, down 1.10%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
Bioceres Crop Solutions Corp. (BIOX) has a latest verified close of 0.36, down 1.10%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for BIOX?Bioceres Crop Solutions Corp. (BIOX) has a latest verified close of 0.36, down 1.10%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...
Bioceres Crop Solutions Corp. (BIOX) has a latest verified close of 0.36, down 1.10%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files BIOX under USA Stocks for browsing.
How often is the BIOX page updated?The BIOX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The BIOX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for BIOX?The BIOX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:BIOX. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The BIOX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:BIOX. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on BIOX?Yes. The workstation can open BIOX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open BIOX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this BIOX page investment advice?No. The BIOX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The BIOX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
BIOX
Equity · evidence first